期刊文献+

尼群地平缓释微丸的制备及体外释放影响因素考察

Preparation of Nitrendipine Sustained-release Pellets and the Influencing Factors
原文传递
导出
摘要 目的:对影响尼群地平缓释微丸中药物体外释放的制备工艺因素进行考察。方法:采用挤出滚圆法制备尼群地平缓释微丸,通过体外释放度试验,对影响缓释微丸中药物释放的润湿剂乙醇浓度及用量、挤出速度、滚圆转速及滚圆时间等因素进行考察,优化制备工艺条件。结果:润湿剂用量及乙醇浓度对药物体外释放影响显著,乙醇浓度应在35%以下,用量宜控制在44mL左右。挤出速度、滚圆转速及滚圆时间等对药物体外释放有一定的影响,分别以48r.min-1、1400r.min-1、5min为宜。结论:采用上述制备工艺,可制得释药速度符合要求的尼群地平缓释微丸。 OBJECTIVE: To investigate the technological factors that influence the drug release of nitrendipine sustained- release pellets. METHODS: The nitrendipine sustained- release pellets were prepared by extrusion- spheronization technology. By means of in vitro drug release test, the factors that influence the drug release including the amount of the wetting agent and the concentration of ethanol,, extrusion speed, spheronisation speed and spheronisation time were investigated to optimize the technological conditions. RESULTS: The amount of the wetting agent and the concentration of ethanol had significant effects on drug release. The optimal concentration of ethanol was less than 35% and the optimal amount of the wetting agent was about 44 mL. Extrusion speed, spheronisation speed and spheronisation time had certain effects on drug release, and their optimal values were 48 r ·min^-1, 1 400 r · min^-1 and 5 min, respectively. CONCLUSION: The nitrendipine sustained - release pellets prepared in the above - mentioned technological conditions are up to the standard in drug release velocity.
机构地区 苏州大学药学院
出处 《中国药房》 CAS CSCD 北大核心 2009年第16期1237-1239,共3页 China Pharmacy
关键词 尼群地平 缓释微丸 体外释放 影响因素 Nitrendipine Sustained- release pellet Release in vitro Influencing factor
  • 相关文献

参考文献6

二级参考文献21

  • 1张金莲,罗文华,田颖刚,黄振宇.高效液相法测定当归补血片中阿魏酸的含量[J].江西中医学院学报,2004,16(4):43-44. 被引量:3
  • 2毛凤斐 屠锡德 等.黄芩甙大鼠小肠吸收的研究[J].南京药学院学报,1984,15(1):61-61.
  • 3Becrt L,Remon J P. Influence of amount of granulation liquid on the drug release rate from pellets made by extrusion spheronization[J ]. Int J Pharm, 1993,95 (1) : 135.
  • 4NESBITT R U, MAHJOUR M, NANCY L M, et al.Effect of substrate on mass release latex coated pellets[ J ]. J Control Release, 1994, 32 ( 1 ) : 71 - 77.
  • 5MOHAMMED A. Al-Omar nimodipine: Drug metabolism and pharmacokinetic profile [ J ]. Profiles of Drug Substances, Exeipients and Related Methodology,2005(31) :371 - 375.
  • 6刘海峡.尼莫地平的临床应用[J].河南实用神经疾病杂志,2000,3(6):60-61.
  • 7FABRIZIO F, CRISTINA F, ELDA D G, et al. Nimodipine selectively stimulates β-amyloid 1-42 secretion by a mechanism independent of ealeium influx blockage[J]. Neurobiology of Aging, 2006, 27(2) :218 - 227.
  • 8PATRIZIA B, RENATO U, DE ARIANNA L, et al.Nimodipine: Drug pharmacokinetics and plasma adenosine levels in patients affected by cerebral ischemia [J].Clinical Pharmacology & Therapeutics, 2002, 72 ( 5 ) :556- 561.
  • 9ISSAC C S. Pharmaceutical pelletization technology[ M]. New York: Marcel Dekker Inc, 1989:101- 143.
  • 10潘家祯,孙晓明,朱大滨,陈庆华,包泳初,陈挺.挤出滚圆法制备药用微丸 Ⅰ.设备的工作原理及特点[J].中国医药工业杂志,1998,29(8):378-380. 被引量:35

共引文献101

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部